These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5450560)

  • 1. [Long-term treatment of hypertension with debrisoquin sulfate].
    Hammarström S
    Lakartidningen; 1970 Jun; 67(23):2663-8. PubMed ID: 5450560
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic results with the hypotensive agent Declinax (debrisoquin) in mild and medium forms of hypertension].
    Bückert A; Schweda E; Vich V
    Schweiz Rundsch Med Prax; 1973 Nov; 62(47):1453-60. PubMed ID: 4202234
    [No Abstract]   [Full Text] [Related]  

  • 3. Debrisoquin sulfate: a clinical evaluation of a new antihypertensive agent.
    Blechman M; Sokol C; Moser M
    Curr Ther Res Clin Exp; 1969 Feb; 11(2):71-6. PubMed ID: 4975816
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with a new postganglionie blockader (Debriosquin, R0-5-3307)].
    Ocon Pujadas J
    Rev Clin Esp; 1972 Jun; 125(6):521-32. PubMed ID: 5074965
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical follow-up of a group of hypertensive patients during the year after finishing a therapeutic study with a new hypotensive drug].
    Ocon Pujadas J
    Rev Clin Esp; 1973 Feb; 128(4):331-6. PubMed ID: 4700584
    [No Abstract]   [Full Text] [Related]  

  • 6. [New sympathoplegic antihypersensive agent: debrisoquin sulfate].
    Biron P
    Union Med Can; 1973 May; 102(5):1134-5. PubMed ID: 4712043
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials with Tendor (debrisoquine sulfate).
    Langer L; Gerö A
    Ther Hung; 1974; 22(4):165-71. PubMed ID: 4465961
    [No Abstract]   [Full Text] [Related]  

  • 9. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
    Larochelle P; Haynes B; Maron N; Dugas S
    Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Debrisoquine, guanethidine, and bethanidine in hypertension.
    Talbot S; O'Malley BC; Bing RH
    Br Med J; 1975 May; 2(5965):278. PubMed ID: 1131592
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical safety and effectiveness of indorenate in essential hypertension.
    Huape-Arreola S; Herrera-Abarca JE; Ruiz-Vega H; Hong E
    Proc West Pharmacol Soc; 2002; 45():197-8. PubMed ID: 12434580
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: Adrenergic-neuron and beta-receptor blockade in hypertension.
    Lancet; 1976 May; 1(7968):1060-1. PubMed ID: 57459
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hypertension with the preparation Tendor].
    Stanchev A; Shishmanova Iu; Sheĭtanov I; Georgiev I
    Vutr Boles; 1977; 16(6):34-8. PubMed ID: 341531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term drug therapy of arterial hypertension including patient compliance].
    Linss G; Kiesewetter R
    Z Arztl Fortbild (Jena); 1984; 78(24):1047-53. PubMed ID: 6442069
    [No Abstract]   [Full Text] [Related]  

  • 15. [New antihypertensive drugs. II. Debrisoquin or Declinax].
    Amery A; Deruyttere M; Fagard R; Koninckx P
    Acta Clin Belg; 1970; 25(5):317-34. PubMed ID: 5513889
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the hypotensive effect of debrisoquin sulfate (Declinax)].
    Honorato F; Ortolá RP
    Rev Med Univ Navarra; 1973 Dec; 17(4):339-44. PubMed ID: 4807215
    [No Abstract]   [Full Text] [Related]  

  • 17. [Problems in evaluating the long-term effect of antihypertensive drugs: once again: the trough/peak ratio].
    Hitzenberger G
    Wien Med Wochenschr; 1997; 147(14):333-5. PubMed ID: 9381727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Persistent orthostatic hypotonia following guanacline therapy].
    Bock KD; Heimsoth V
    Dtsch Med Wochenschr; 1969 Feb; 94(6):256-6 passim. PubMed ID: 5762679
    [No Abstract]   [Full Text] [Related]  

  • 19. Current trends in the treatment of hypertension.
    Wasir HS; Agarwal R
    J Assoc Physicians India; 1993 Nov; 41(11):725-30. PubMed ID: 8005931
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of phenytoin and conventional drug therapy in the treatment of mild hypertension.
    de la Torre R; murgía-Suarez JJ; Aldrete J
    Clin Ther; 1980; 3(2):117-24. PubMed ID: 7448841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.